Literature DB >> 15878905

Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis.

T R D J Radstake1, A W T van Lieshout, P L C M van Riel, W B van den Berg, G J Adema.   

Abstract

Recent findings suggest an important role for Fcgamma receptors and Toll-like receptors expressed by dendritic cells (DC) in the pathogenesis of rheumatoid arthritis (RA). Possibly, DC behaviour might be tuned to counteract the misbalanced immune system in RA. Understanding the precise mechanisms that determine the skewed immune response in RA may provide new clues for the therapeutic use of DC in RA.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15878905      PMCID： PMC1755288          DOI： 10.1136/ard.2004.033779

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  91 in total

Review 1.  Dendritic cells: emerging pharmacological targets of immunosuppressive drugs.

Authors:  Holger Hackstein; Angus W Thomson
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

2.  Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis.

Authors:  P S Sorensen; B Wanscher; C V Jensen; K Schreiber; M Blinkenberg; M Ravnborg; H Kirsmeier; V A Larsen; M L Lee
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

3.  Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.

Authors:  F O Nestle; S Alijagic; M Gilliet; Y Sun; S Grabbe; R Dummer; G Burg; D Schadendorf
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

4.  Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells.

Authors:  N A Fanger; D Voigtlaender; C Liu; S Swink; K Wardwell; J Fisher; R F Graziano; L C Pfefferkorn; P M Guyre
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

5.  The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes.

Authors:  Peter van Lent; Karin C Nabbe; Peter Boross; Arjen B Blom; Johannes Roth; Astrid Holthuysen; Annet Sloetjes; Sjef Verbeek; Wim van den Berg
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

6.  Aberrant extracellular and dendritic cell (DC) surface expression of heat shock protein (hsp)70 in the rheumatoid joint: possible mechanisms of hsp/DC-mediated cross-priming.

Authors:  Carla A Martin; Steven E Carsons; Robert Kowalewski; David Bernstein; Michael Valentino; Frances Santiago-Schwarz
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

7.  Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.

Authors:  Dave L Roelen; Danita H Schuurhuis; Daniëlle E M van den Boogaardt; Karin Koekkoek; Paula P M C van Miert; Jolien J van Schip; Sandra Laban; Delphine Rea; Cees J M Melief; Rienk Offringa; Ferry Ossendorp; Frans H J Claas
Journal:  Transplantation       Date:  2003-12-15       Impact factor: 4.939

8.  Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.

Authors:  I Jolanda M de Vries; W Joost Lesterhuis; Nicole M Scharenborg; Linda P H Engelen; Dirk J Ruiter; Marie-Jeanne P Gerritsen; Sandra Croockewit; Cedrik M Britten; Ruurd Torensma; Gosse J Adema; Carl G Figdor; Cornelis J A Punt
Journal:  Clin Cancer Res       Date:  2003-11-01       Impact factor: 12.531

9.  Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.

Authors:  Joel M Kremer; Rene Westhovens; Marc Leon; Eduardo Di Giorgio; Rieke Alten; Serge Steinfeld; Anthony Russell; Maxime Dougados; Paul Emery; Isaac F Nuamah; G Rhys Williams; Jean-Claude Becker; David T Hagerty; Larry W Moreland
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

10.  Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis.

Authors:  T Yuasa; S Kubo; T Yoshino; A Ujike; K Matsumura; M Ono; J V Ravetch; T Takai
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307
View more
  7 in total

1.  Collagen induces maturation of human monocyte-derived dendritic cells by signaling through osteoclast-associated receptor.

Authors:  Heidi S Schultz; Louise M Nitze; Louise H Zeuthen; Pernille Keller; Albrecht Gruhler; Jesper Pass; Jianhe Chen; Li Guo; Andrew J Fleetwood; John A Hamilton; Martin W Berchtold; Svetlana Panina
Journal:  J Immunol       Date:  2015-02-27       Impact factor: 5.422

2.  Characterisation of a dendritic cell subset in synovial tissue which strongly expresses Jak/STAT transcription factors from patients with rheumatoid arthritis.

Authors:  J G Walker; M J Ahern; M Coleman; H Weedon; V Papangelis; D Beroukas; P J Roberts-Thomson; M D Smith
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

3.  Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs.

Authors:  Yuya Takakubo; Yasunobu Tamaki; Tomoyuki Hirayama; Kiyoshi Iwazaki; Kan Sasaki; Akiko Sasaki; Hiroharu Ohki; Noe Takakubo; Yrjö T Konttinen; Michiaki Takagi
Journal:  Clin Rheumatol       Date:  2013-02-10       Impact factor: 2.980

4.  Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development.

Authors:  Caroline Aspord; Alexander Pedroza-Gonzalez; Mike Gallegos; Sasha Tindle; Elizabeth C Burton; Dan Su; Florentina Marches; Jacques Banchereau; A Karolina Palucka
Journal:  J Exp Med       Date:  2007-04-16       Impact factor: 14.307

5.  Increased toll-like receptor 2 expression in peptidoglycan-treated blood monocytes is associated with insulin resistance in patients with nondiabetic rheumatoid arthritis.

Authors:  Shih-Wei Wang; Tsun-Mei Lin; Chiou-Huey Wang; Hsiao-Han Liu; Jer-Yiing Houng
Journal:  Mediators Inflamm       Date:  2012-11-20       Impact factor: 4.711

6.  Increased responsiveness to toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis.

Authors:  M L Kowalski; A Wolska; J Grzegorczyk; J Hilt; M Jarzebska; M Drobniewski; M Synder; M Kurowski
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

7.  Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis.

Authors:  Yoshifumi Tada; Syuichi Koarada; Fumitaka Morito; Mio Mitamura; Hisako Inoue; Rie Suematsu; Akihide Ohta; Kensuke Miyake; Kohei Nagasawa
Journal:  Arthritis Res Ther       Date:  2008-10-11       Impact factor: 5.156
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.